Company Description
Vertex Pharmaceuticals represents the convergence of drug discovery technologies. The biotechnology company uses an integrated, multidisciplinary...
Key Vertex Pharmaceuticals Financials
| Company Type | Public - NASDAQ (GS): VRTX Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $199.0 |
| 2007 Employees | 1,150 |
More Vertex Pharmaceuticals Financials (11 pages)
Latest Vertex Pharmaceuticals Jobs jobs by Indeed
Rankings
- S&P 400
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Vertex Pharmaceuticals's competition across multiple industries
Top Vertex Pharmaceuticals Competitors
Sponsored Links
The Business Directory
Vertex Pharmaceuticals Executives
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Joshua S. Boger | Network | E-mail |
| EVP and CFO | Ian F. Smith | Network | E-mail |
| VP and CTO | Mark Murcko | Network | E-mail |
More Vertex Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Vertex Pharmaceuticals News
- Nasdaq 100 Winners: Level 3, Infosys, Liberty Global [Midnight Trader] (26 Aug 2008 13:22:00 EDT)
- BioWorld Today August 26, 2008 [BioWorld Today] (26 Aug 2008 00:01:00 EDT)
- Gyrase inhibitors and uses thereof [U.S. Patents] (25 Aug 2008 12:25:00 EDT)
Sponsored Opportunity
